Yuhan Corp Preferred (000105) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.035x

Based on the latest financial reports, Yuhan Corp Preferred (000105) has a cash flow conversion efficiency ratio of 0.035x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩76.86 Billion ≈ $52.08 Million USD) by net assets (₩2.22 Trillion ≈ $1.50 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Yuhan Corp Preferred - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Yuhan Corp Preferred's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 000105 total debt and obligations for a breakdown of total debt and financial obligations.

Yuhan Corp Preferred Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuhan Corp Preferred ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
DANIEL THWAITES LS-25
F:7KW
N/A
The Intergroup Corporation
NASDAQ:INTG
0.032x
Onward Technologies Limited
NSE:ONWARDTEC
0.151x
Jati Tinggi Group Berhad
KLSE:0292
-0.081x
Ekinops SA
PA:EKI
0.004x
Dagi Giyim Sanayi ve Ticaret AS
IS:DAGI
0.174x
KB No.2 Special Purpose Acq
KQ:192250
-0.002x
UIL Co. Ltd
KQ:049520
0.116x

Annual Cash Flow Conversion Efficiency for Yuhan Corp Preferred (2014–2024)

The table below shows the annual cash flow conversion efficiency of Yuhan Corp Preferred from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Yuhan Corp Preferred stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩2.15 Trillion
≈ $1.46 Billion
₩54.60 Billion
≈ $37.00 Million
0.025x -60.58%
2023-12-31 ₩1.98 Trillion
≈ $1.34 Billion
₩127.75 Billion
≈ $86.58 Million
0.064x +29.92%
2022-12-31 ₩2.01 Trillion
≈ $1.36 Billion
₩99.53 Billion
≈ $67.45 Million
0.050x -3.07%
2021-12-31 ₩1.94 Trillion
≈ $1.31 Billion
₩99.00 Billion
≈ $67.09 Million
0.051x +227.54%
2020-12-31 ₩1.85 Trillion
≈ $1.25 Billion
₩28.83 Billion
≈ $19.54 Million
0.016x -60.96%
2019-12-31 ₩1.65 Trillion
≈ $1.12 Billion
₩65.99 Billion
≈ $44.72 Million
0.040x -29.32%
2018-12-31 ₩1.65 Trillion
≈ $1.12 Billion
₩93.45 Billion
≈ $63.33 Million
0.057x -27.94%
2017-12-31 ₩1.61 Trillion
≈ $1.09 Billion
₩126.13 Billion
≈ $85.47 Million
0.079x +58.48%
2016-12-31 ₩1.50 Trillion
≈ $1.01 Billion
₩74.14 Billion
≈ $50.25 Million
0.050x -46.47%
2015-12-31 ₩1.36 Trillion
≈ $924.32 Million
₩126.23 Billion
≈ $85.55 Million
0.093x +25.11%
2014-12-31 ₩1.28 Trillion
≈ $864.64 Million
₩94.39 Billion
≈ $63.96 Million
0.074x --

About Yuhan Corp Preferred

KO:000105 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$59.61 Million
₩87.96 Billion KRW
Market Cap Rank
#21214 Global
#1335 in Korea
Share Price
₩76600.00
Change (1 day)
-1.54%
52-Week Range
₩76600.00 - ₩113300.00
All Time High
₩188400.00
About

Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.